<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang S</submitter><funding>Shuguang Project</funding><funding>Shanghai Outstanding Academic Leaders</funding><funding>National Natural Science Foundation of China</funding><funding>Innovative research team of high-level local universities in Shanghai</funding><funding>Shanghai Sailing Program</funding><pagination>265</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9716717</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Dimethylarginine dimethylaminohydrolase (DDAH) 1 maintains the bioavailability of nitric oxide by degrading asymmetric dimethylarginine (ADMA). Here, we aimed to investigate the effect of haptoglobin (Hp) genotype on the association of ADMA and DDAH 1 polymorphism with diabetic macroangiopathy.&lt;h4>Methods&lt;/h4>In stage 1, 90 Chinese participants with type 2 diabetes were enrolled to measure a panel of targeted metabolites, including ADMA, using tandem mass spectrometry (BIOCRATES AbsoluteIDQ™ p180 kit). In stage 2, an independent cohort of 2965 Chinese patients with type 2 diabetes was recruited to analyze the effect of Hp genotype on the association between DDAH 1 rs233109 and diabetic macroangiopathy. Hp genotypes were detected using a validated assay based on the TaqMan method. DDAH 1 rs233109 was genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy using the MassARRAY platform.&lt;h4>Results&lt;/h4>In stage 1, serum ADMA levels correlated with common Hp genotypes (β ± SE = - 0.049 ± 0.023, P = 0.035), but not with diabetic macroangiopathy (P = 0.316). In stage 2, the distribution of DDAH 1 rs233109 genotype frequencies was 15% (CC), 47% (TC), and 38% (TT), which was in Hardy-Weinberg equilibrium (P = 0.948). A significant Hp genotype by rs 233109 genotype interaction effect on diabetic macroangiopathy was found (P = 0.017). After adjusting for confounders, patients homozygous for rs233109 CC were more likely to develop diabetic macroangiopathy than those carrying TT homozygotes in the Hp 2-2 subgroup [odds ratio = 1.750 (95% confidence interval, 1.101-2.783), P = 0.018].&lt;h4>Conclusion&lt;/h4>Hp genotype affects the association between DDAH 1 rs233109 and diabetic macroangiopathy in Chinese patients with type 2 diabetes.</pubmed_abstract><journal>Cardiovascular diabetology</journal><pubmed_title>The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy.</pubmed_title><pmcid>PMC9716717</pmcid><funding_grant_id>82000772</funding_grant_id><funding_grant_id>SHSMU-ZDCX20212700</funding_grant_id><funding_grant_id>20YF1435700</funding_grant_id><funding_grant_id>21SG11</funding_grant_id><funding_grant_id>20XD1433300</funding_grant_id><funding_grant_id>81974118</funding_grant_id><pubmed_authors>Hu C</pubmed_authors><pubmed_authors>Zheng X</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Deng Z</pubmed_authors><pubmed_authors>Yan D</pubmed_authors><pubmed_authors>Jia W</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors></additional><is_claimable>false</is_claimable><name>The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy.</name><description>&lt;h4>Background&lt;/h4>Dimethylarginine dimethylaminohydrolase (DDAH) 1 maintains the bioavailability of nitric oxide by degrading asymmetric dimethylarginine (ADMA). Here, we aimed to investigate the effect of haptoglobin (Hp) genotype on the association of ADMA and DDAH 1 polymorphism with diabetic macroangiopathy.&lt;h4>Methods&lt;/h4>In stage 1, 90 Chinese participants with type 2 diabetes were enrolled to measure a panel of targeted metabolites, including ADMA, using tandem mass spectrometry (BIOCRATES AbsoluteIDQ™ p180 kit). In stage 2, an independent cohort of 2965 Chinese patients with type 2 diabetes was recruited to analyze the effect of Hp genotype on the association between DDAH 1 rs233109 and diabetic macroangiopathy. Hp genotypes were detected using a validated assay based on the TaqMan method. DDAH 1 rs233109 was genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy using the MassARRAY platform.&lt;h4>Results&lt;/h4>In stage 1, serum ADMA levels correlated with common Hp genotypes (β ± SE = - 0.049 ± 0.023, P = 0.035), but not with diabetic macroangiopathy (P = 0.316). In stage 2, the distribution of DDAH 1 rs233109 genotype frequencies was 15% (CC), 47% (TC), and 38% (TT), which was in Hardy-Weinberg equilibrium (P = 0.948). A significant Hp genotype by rs 233109 genotype interaction effect on diabetic macroangiopathy was found (P = 0.017). After adjusting for confounders, patients homozygous for rs233109 CC were more likely to develop diabetic macroangiopathy than those carrying TT homozygotes in the Hp 2-2 subgroup [odds ratio = 1.750 (95% confidence interval, 1.101-2.783), P = 0.018].&lt;h4>Conclusion&lt;/h4>Hp genotype affects the association between DDAH 1 rs233109 and diabetic macroangiopathy in Chinese patients with type 2 diabetes.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-05-28T21:28:57.19Z</modification><creation>2025-04-19T22:49:25.881Z</creation></dates><accession>S-EPMC9716717</accession><cross_references><pubmed>36461077</pubmed><doi>10.1186/s12933-022-01702-6</doi></cross_references></HashMap>